Emmaus Life Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' DEFICIT (Details 2) (USD $)	12 Months Ended
STOCKHOLDERS' DEFICIT (Details 2) (USD $)	Sep. 30, 2014	Sep. 30, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	$ 1,008,700	$ 1,257,300
Cost of Neurometric Services revenues [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	5,100	10,600
Research [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	65,500	92,700
Product Development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	249,700	113,300
Sales and marketing [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	87,700	155,500
General and administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expenses	$ 600,700	$ 885,200